NCBiotech News

Leaders of eight fast-emerging North Carolina agricultural biotechnology companies will pitch their wares to investors and other interested observers October 10 at the 2013 Ag Biotech Entrepreneurial Showcase.
 

Polarean, a Duke University spinout bootstrapped by an NCBiotech loan, has filed a new drug application with the FDA for its unique technology for lung imaging.

Grifols, a global biotherapeutics company, has begun Phase 3 clinical trials in patients with COVID-19 with its therapeutic manufactured in Clayton.

Burlington-based LabCorp has received Emergency Use Authorization from the U.S. Food and Drug Administration to deploy an improved laboratory test for detecting the coronavirus infection.

Greensboro diagnostics and drug screening company Carolina Liquid Chemistries has added another COVID-19 test kit to its product line.

Getting accurate, timely information on COVID-19 cases is one of the major challenges facing policymakers as they make decisions about public health and the economy. Researchers at North Carolina State University are embarking on a project aimed at making sure test kits are available where they are most needed, so that policymakers have the information they need.

RedHill Biopharma, an Israeli company with U.S. headquarters in Raleigh, says one of its drug candidates, opaganib, completely inhibited the replication of the coronavirus that causes COVID-19 in a laboratory study.

GeneCoda executive Don Alexander shares results of a 100-company survey his team conducted to understand the COVID-19 impact on life sciences businesses.

RTI International and Duke University’s Human Vaccine Institute will collaborate in a global project to identify viruses and other pathogens in wildlife that could cause disease in people, such as the coronavirus responsible for the COVID-19 pandemic

Development-stage pharmaceutical start-up Propella Therapeutics Inc. has just received a patent for its metastatic prostate cancer treatment, PRL-02.

EternaTear, young Raleigh startup developing a non-prescription eyedrop to treat dry eye syndrome, says it has raised $4.9 million in an oversubscribed Series A round of funding.

Global pharmaceutical giant Eli Lilly and Company will build its first North Carolina manufacturing facility in the Durham County portion of Research Triangle Park, investing $474 million and creating 462 new jobs.

Clemens, along with associate professor Kori Brewer, examine a mouse’s spinal column in their lab at the Brody School of Medicine. Clemens’ work with mouse models was essential in helping him develop his Restless Legs Syndrome treatment.

October is Breast Cancer Awareness Month, and a Research Triangle Park company developing a unique breast reconstruction option for mastectomy patients is raising awareness with its investment support.

NC's life sciences successes have earned Governor Roy Cooper the honor of the BIO 2020 Governor of the Year.